Klasther Biopharma is an innovative biotech startup that develops Antibody-Drug Conjugates for cancer treatment. It leverages on a revolutionary principle that allows the antibody to distinguish between normal and cancer cells, thus delivering the cytotoxic payload specifically to the tumor.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Via Nizza, 52, Molecular Biotechnology Center,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Targeted therapy of cancer, Antibody-Drug Conjugates, Biotechnology, Oncology, Cancer metabolism.
- HQ
- Turin, Piedmont
Klasther Biopharma Questions
Klasther Biopharma's LinkedIn profile is https://it.linkedin.com/company/klasther
Klasther Biopharma has
4 employees.
View email and phone details for 4
employees at Klasther Biopharma.
Klasther Biopharma's industry is
Biotechnology Research
Klasther Biopharma's top competitors are
Officina Farmaceutica "università Degli Studi Di Torino",
Gem Forlab S.r.l.,
Euremab,
Evobiotech,
Rosebio,
Agomab,
Resalis Therapeutics,
Kedrion Biopharma,
Reithera,
Rasgenix Srl.
Klasther Biopharma's categories are Biotechnology Research
Klasther Biopharma's founding year is 2024
